6 minute read
May 13, 2022
Lenrispodun: a Phosphodiesterase (PDE) Type 1 (PDE1) Inhibitor
lenrispodun
oral, CNS-penetrant, picomolar PDE1 inhibitor Ph. I/II in neurology and heart failure from literature starting point, LBDD and SBDD Neuropsychopharmacology Intra-Cellular Therapies, New York, NY